• Profile
Close

Neutrophil-to-lymphocyte ratio as a prognostic marker in patients with metastatic gallbladder cancer

Journal of Clinical Oncology Feb 05, 2019

Mady M, et al. - In patients with metastatic gallbladder cancer (GBC) treated at the Mayo Clinic between 2000 and 2016, neutrophil to lymphocyte ratio (NLR) was assessed as an independent predictor of overall survival. Patients who did not have data for neutrophils and lymphocytes were excluded. By plotting martingale residuals against NLR, the optimal cutoff point for NLR was identified. Researchers used Cox-proportional hazard regression to perform multivariate survival analysis. Of 231 patients included, 138 (60%) had NLR < 5 and 93 (40%) had NLR ≥ 5. Older age, poor performance score, lower albumin level, higher alkaline phosphatase level, and higher platelet count were more likely among patients with NLR ≥ 5. A worse overall survival was observed in association with NLR of ≥ 5 vs NLR < 5 in multivariate analysis, adjusting for age, ECOG status, albumin, ALP, AST, ALT, bilirubin, platelet count and administration of chemotherapy. NLR ≥ 5 was identified as an independently predicts poor prognosis in this patient population.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay